Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00001445
What this trial is testing

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT00117429
What this trial is testing

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Marcus Altfeld, M.D., Ph.D. 20
Testing effectiveness (Phase 2)WithdrawnNCT02462772
What this trial is testing

Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa

Who this might be right for
Human Immunodeficiency Virus
Centre for the AIDS Programme of Research in South Africa
Not applicableStudy completedNCT00183287
What this trial is testing

Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Post-approval studies (Phase 4)Ended earlyNCT01676363
What this trial is testing

Pilot Study of Diflunisal in HIV-infected Adults

Who this might be right for
HIV Infection
University of British Columbia 8
Post-approval studies (Phase 4)Study completedNCT00924898
What this trial is testing

Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)

Who this might be right for
Acute HIV InfectionHIV Infections
University of North Carolina, Chapel Hill 92
Not applicableStudy completedNCT01897909
What this trial is testing

The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana

Who this might be right for
HIVBacterial Infection Due to Helicobacter Pylori (H. Pylori)
Bernhard Nocht Institute for Tropical Medicine 1,100
Early research (Phase 1)Temporarily pausedNCT06905275
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableNo Longer AvailableNCT00162227
What this trial is testing

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

Who this might be right for
HIV Infection
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT01009762
What this trial is testing

Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection

Who this might be right for
HIV INFECTIONS
Gitte Kronborg 11
Very early researchUnknownNCT03174977
What this trial is testing

Pharmacokinetics Distribution of Raltegravir by PET/MR

Who this might be right for
HIV-1-infection
University of California, San Francisco 10
Early research (Phase 1)Study completedNCT00001005
What this trial is testing

Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT00460746
What this trial is testing

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

Who this might be right for
HIV
Tibotec, Inc 10
Large-scale testing (Phase 3)Study completedNCT00363142
What this trial is testing

An Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects

Who this might be right for
HIV InfectionInfection, Human Immunodeficiency Virus
GlaxoSmithKline 211
Not applicableStudy completedNCT04772469
What this trial is testing

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

Who this might be right for
Human Immunodeficiency VirusAcquired Immunodeficiency SyndromeHIV Infections+5 more
University of California, San Francisco 934
Large-scale testing (Phase 3)Study completedNCT03227861
What this trial is testing

Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care

Who this might be right for
HIV-1
Janssen Scientific Affairs, LLC 109
Not applicableStudy completedNCT05358366
What this trial is testing

Love Infection: A Dramatized Story Intervention (Telenovela/Soap Opera) for HIV Prevention

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 58
Early research (Phase 1)Study completedNCT05144386
What this trial is testing

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

Who this might be right for
HIV-1-infection
Excision BioTherapeutics 6
Large-scale testing (Phase 3)Study completedNCT03446573
What this trial is testing

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Who this might be right for
HIV Infections
ViiV Healthcare 743
Testing effectiveness (Phase 2)Study completedNCT01725542
What this trial is testing

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders

Who this might be right for
HCV-HIV Co-Infection
ANRS, Emerging Infectious Diseases 75
Next Page